Categories: BrainNews

Soterix Medical Announces FDA 510(k) Clearance of MEGA-IOM Intraoperative Neuromonitoring System

WOODBRIDGE, N.J., July 24, 2024 /PRNewswire/ — Soterix Medical Inc., the global leader in stimulation and synergistic monitoring technologies, announced today it has received a 510(k) clearance from the U.S. Food & Drug Administration for its Intraoperative Neurophysiologic Monitoring (IOM) system, MEGA-IOM. The system provides unmatched integrated control of central and peripheral nervous systems to reduce postoperative risk and improve surgical outcomes. ­It includes preset modalities such as motor evoked potentials (MEP) to evaluate the integrity of motor pathways, somatosensory evoked potentials (SSEP) to evaluate the integrity of sensory pathways and detect brain and spinal cord ischemia, EEG to record and analyze brain activity (functional state of the brain), and direct stimulation to control the functional integrity of peripheral nerves.

MEGA-IOM provides unmatched integrated control of central and peripheral nervous systems to reduce postoperative risk.

“This FDA authorization represents a significant milestone for our organization as we can now offer the MEGA-IOM system to surgical teams across the U.S.,” said Ms. Danielle Dadona, VP of Regulatory Affairs of Soterix Medical. “This U.S. manufactured system pairs with an intuitive, rich, software interface with exceptional usability.”

Mr. Kamran Nazim, Chief Product Officer of Soterix Medical commented “MEGA-IOM is a cutting-edge modular platform solution that combines years of knowledge and experience obtained in clinical and research environments. Due to flexible channel configuration and size options (cart-based or portable), the system can meet the most exacting needs of both surgeons and advanced neuromonitoring specialists.”

Surgeons, neurophysiologists, neurologists and intraoperative monitoring service companies in the United States interested in incorporating the MEGA-IOM system are eligible for Soterix Medical’s Partnership program which includes support on the entire system, hands-on training and staff certification. Interested parties should contact Soterix Medical (at contact@soterixmedical.com) for additional information.

Media Contact: Chaya Edelman
Tel: +1-888-990-8327
Email: contact@soterixmedical.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/soterix-medical-announces-fda-510k-clearance-of-mega-iom-intraoperative-neuromonitoring-system-302204284.html

SOURCE Soterix Medical, Inc.

Staff

Recent Posts

SS&C Technologies Releases Q2 2024 Earnings Results, Announces $1 Billion Common Stock Repurchase Program

Q2 2024 GAAP revenue $1,451.5 million, up 6.5%, Fully Diluted GAAP Earnings Per Share $0.75,…

4 hours ago

CoachCare Announces $48 Million Investment Led By Integrity Growth Partners

Integrity Growth Partners' investment in the RPM and virtual care management company aims to further…

4 hours ago

Medicom Secures Strategic Expansion Capital from UPMC Enterprises, TGH Ventures, Cone Health Ventures, Customers Bank, and More

RALEIGH, N.C., July 25, 2024 /PRNewswire/ -- Medicom, a health tech startup leading enterprise imaging interoperability,…

4 hours ago

20 Years after Landmark FDA Approval, SynCardia Remains World’s Only Commercially Approved Total Artificial Heart

Few total artificial hearts make it to human clinical trials, and only the SynCardia Total…

4 hours ago

Cadmium Concludes Cadmium Spark 2024 with Exciting Announcements and Awards Ceremony

WASHINGTON, July 25, 2024 /PRNewswire/ -- Cadmium, the leading learning and event technology provider, has officially…

4 hours ago

Artera Expands Support for Underserved Communities With Multiple New Federally Qualified Health Center Partners

Bedford-Stuyvesant Family Health Center and Moses Lake Community Health Center Among 12+ New FQHC Partners…

4 hours ago